https://www.avient.com/sites/default/files/2024-10/Compensation Committee Charter - Final.pdf
Approve the adoption and amendment of Company stock ownership guidelines and annually
review compliance with these guidelines.
3
Non-employee Director Compensation
Review the compensation of non-employee directors and make recommendations to the
Board regarding changes to existing compensation levels.
• Review and recommend to the Board for its approval equity-based grants and awards to non-
employee directors under the Company’s equity-based plans and annually review compliance
with Company stock ownership guidelines.
The Committee may delegate its authority under this Charter relating to employees other than
executive officers and non-employee directors, to the extent it deems appropriate and
consistent with law and customary practice and may otherwise fully delegate authority
relating to matters it deems to be ministerial
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520Jefferies%2520Conf%2520w%2520Non%2520GAAP%252008%252012%25202014.pdf
PolyOne Corporation Page 2
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
A reconciliation of each non-GAAP financial measure with the most directly
comparable GAAP financial measure is attached to this presentation which is posted
on our website at www.polyone.com.
Strong past performance demonstrates that our strategy and
execution are working
Megatrends and emerging opportunities align with our strengths
Innovation and services provide differentiation, incremental pricing
power, and competitive advantage
Strong and proven management team driving growth and
performance
Addressable market exceeds $40 billion
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520GS%2520w%2520non%2520GAAP%25205_21_14.pdf
Forward – Looking Statements
Page 2
• This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
A reconciliation of each non-GAAP financial measure with the most directly
comparable GAAP financial measure is attached to this presentation which is
posted on our website at www.polyone.com.
Strong past performance demonstrates that our strategy and execution
are working
Megatrends and emerging opportunities align with our strengths
Innovation and services provide differentiation, incremental pricing
power, and competitive advantage
Strong and proven management team driving growth and performance
Addressable market exceeds $40 billion
Page 15
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and
presented in accordance with U.S.
https://www.avient.com/sites/default/files/2023-03/2023 Avient Bookmarked Proxy Statement - FINAL.pdf
Grants to Non-U.S.
Awards to Non-Employee Directors.
Non U.S.
https://www.avient.com/sites/default/files/2020-08/colormatrix-flexcart-nano-liquid-metering-system-flyer_0.pdf
The FlexCart Nano
unit is designed to operate with non-continuous
processes.
EQUIPMENT SPECIFICATION
The FlexCart Nano unit is a non-configurable, stand-
alone unit, and it is specifically designed for small
output operations.
Key questions for deciding on a FlexCart Nano unit
include the type of operation involved and what your
process requires:
• Is the process non-continuous?
https://www.avient.com/sites/default/files/2020-05/polyone-investor-presentation-may-2020_0.pdf
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or
solely as alternatives to, financial measures prepared in accordance with GAAP.
Below is a reconciliation of these non-GAAP financial measures to their most directly comparable financial measures
calculated and presented in accordance with GAAP.
Below is a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure calculated and presented in accordance with GAAP.
https://www.avient.com/sites/default/files/2020-09/chemically-compatible-tpes-for-cosmetic-pkg-application-bulletin.pdf
VERSAFLEX PKG
4345, 4355, 4365
VERSAFLEX PKG
4465
VERSAFLEX PKG
4570
VERSAFLEX PKG
4665
Chemical
Compatibility
Soaps, low-cost
solution for
non-polar oils
Soaps, some oils Polar & non-polar oils,
non-polar solvents
Non-polar oils
(abrasion resistant)
Regulatory
Compliance*
REACH SVHC,
FDA 21 CFR
EU 10/2011
REACH SVHC &
FDA 21 CFR
FDA CFR
FDA CFR
Hardness 45A, 55A, 65A 65A 70A 65A
Overmolded
Substrate Polypropylene Polypropylene
Polycarbonate
ABS
PC/ABS
Polycarbonate
ABS
PC/ABS
Color Translucent Translucent Natural Natural
* Please contact Avient for additional information
HOW CHEMICALLY COMPATIBLE VERSAFLEX PKG TPEs MAKE THE DIFFERENCE
IN COSMETIC PACKAGING
Chemical compatibility – Versaflex PKG TPEs do
not discolor, etch, crack or delaminate when in
contact with most soaps, lotions, oils, surfactants
and solvents found in cosmetics.
https://www.avient.com/sites/default/files/2020-05/1.-polyone-ir-presenstation-fermium-research-chemicals-conference.pdf
Below is a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure calculated and presented in accordance withGAAP.
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as
alternatives to, financial measures prepared in accordance with GAAP.
Below is a reconciliation of these non-GAAP financial measures to their most directly comparable financial measures
calculated and presented in accordance with GAAP.
https://www.avient.com/sites/default/files/2020-05/2.-polyone-ir-presenstation-wells-fargo-industrials-conference.pdf
Below is a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure calculated and presented in accordance withGAAP.
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or solely as
alternatives to, financial measures prepared in accordance with GAAP.
Below is a reconciliation of these non-GAAP financial measures to their most directly comparable financial measures
calculated and presented in accordance with GAAP.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Functional Additives Pharma Pkg Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without animal-
derived substances
• Available for use in a wide range of polymers
including polyolefins, styrenics, polycarbonate
and alloys, polyester, POM
• Functionality can be combined with colorants
into convenient combination concentrates or
formulations
REGULATORY SUPPORT
• Pre-tested raw materials:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III)
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request
FUNCTIONALITY TARGET APPLICATIONS EBM/IBM
CONTAINERS CLOSURES FILM COMBINATION
DEVICES
Clarifying PP Sorbitol-free—possibilities in
packaging ocular solutions
Slip/torque reduction Slip for PE, PP films, processing aid,
torque reduction for closures
Protection from UV in
transparent packaging
for PP, PE, PETG, COP
UV blocking in 290–450nm with
no impact on clarity
Antistatic ready-to-use
solution for PE films e.g.
for API handling
Permanent/non-migrating;
fast decay time independent
of % relative humidity
Antistatic masterbatch
for PE films
Cost effective, long-lasting, migrating
type but with biological evaluation
Gamma/e-beam
sterilization protection
of the polymer
Preserving the properties of PP and
COC/COP.
Reduction in yellowing using
Color Compensation Technology (CCT)
Reduced material
consumption/cycle
time/improved
properties—nucleation
Fast acting new generation
nucleant for PE and PP; improved
dimensional stability, thermal
and mechanical properties
Laser marking replacing
ink printing/labels
Solvent-free, high-speed identification
for Nd/YAG laser
Antiblock for
PE/PP film
Non-migrating additive system
maintaining high gloss and printability
Antioxidants for
PE, PP, TPE
Thermal protection during converting/
downstream sterilization
Brand protection/
anticounterfeit Range of covert and non-covert systems
Volatiles/odor absorber
for PE/PP
Physical absorption of a wide range
of molecules responsible for odor,
VOC and potential extractables/
leachables in plastics
Healthcare use limitations apply—see below.